{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:10:46Z","timestamp":1778659846544,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) continues to rise globally, and the limitations\nof existing therapies highlight the urgent need for novel interventions. Indole derivatives have\nemerged as promising candidates due to their structural adaptability, multi-target engagement, and\nfavorable pharmacokinetic profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a comprehensive review of literature published between 2020 and 2025,\nsystematically searching PubMed, Scopus, and Web of Science for studies on indole-based antidiabetic\nagents. The inclusion criteria emphasized mechanistic insights, structure-activity relationships\n(SAR), preclinical advancements, and early clinical evaluations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Over 120 indole derivatives were identified targeting key diabetes-related pathways, including\nAMPK activation, insulin receptor sensitization, \u03b2-cell protection, and enzyme inhibition (e.g.,\nDPP-4, \u03b1-glucosidase). SAR analyses revealed that position-specific modifications at N1, C2, C3,\nand C5 significantly enhance bioactivity and selectivity. Innovations in synthesis (e.g., microwaveassisted,\ngreen chemistry approaches), formulation (e.g., nanoparticles, prodrugs), and AI-assisted\ndrug design have improved clinical viability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The evidence supports the unique polypharmacological profile of indole scaffolds, enabling\nmulti-pathway modulation and addressing both hyperglycaemia and its complications. Challenges\nremain regarding toxicity, solubility, and translational gaps, but emerging delivery strategies\nand personalized medicine approaches show promise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Indole derivatives represent a transformative class of antidiabetic agents with multitarget\nactivity and strong therapeutic potential, warranting further clinical validation to optimize their\nrole in precision medicine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501428834260416072942","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:32:37Z","timestamp":1778657557000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Target-based Antidiabetic Indole Derivatives and Insights into\nStructure-activity Relationships: A Mechanistic Update 2020-2025"],"prefix":"10.2174","volume":"27","author":[{"given":"Ankita","family":"Wal","sequence":"first","affiliation":[{"name":"PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kanpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranay","family":"Wal","sequence":"additional","affiliation":[{"name":"PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kanpur, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Gupta","sequence":"additional","affiliation":[{"name":"United Institute of Pharmacy, Prayagraj,UP, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Hemalatha","sequence":"additional","affiliation":[{"name":"Department of pharmaceutical Chemistry, Pathfinder Institute of Pharmacy Education and Research,Khammam, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanish Singh Jayasingh","family":"Chellammal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Life Sciences, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), PuncakAlam, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand Badrivishal","family":"Mundada","sequence":"additional","affiliation":[{"name":"R.C. Patel Institute of Pharmaceutical Education and Research Shirpur, District Dhule, Maharashtra,425405, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Gasmi","sequence":"additional","affiliation":[{"name":"Soci\u00e9t\u00e9 Francophone de Nutrith\u00e9rapie et de Nutrig\u00e9n\u00e9tique Appliqu\u00e9e, Villeurbanne, France, villeurbanne,France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501428834260416072942","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/253464\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501428834260416072942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:32:41Z","timestamp":1778657561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/253464\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501428834260416072942","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}